Search results
Vivani to start in-human trial for GLP-1 implant for treating obesity
Clinical Trials Arena· 2 days agoGlobalData is the parent company of Clinical Trials Arena. Weight loss therapies including Novo ...
‘Compounded’ weight-loss drugs are a growing problem for state regulators
West Virginia Watch· 4 days agoAnna Wysock’s “aha” moment arrived in an Ohio amusement park, as she got ready to ride a roller...
Patients on weight-loss drugs should inform doctor before surgery, EU regulator says - ET...
The Economic Times· 1 day agoWeight-loss drugs, including Wegovy and Eli Lilly's Zepbound and Mounjaro, belong to a class known as GLP-1 receptor agonists that slow the process of emptying food contents from the stomach, making users feel full for longer
Eli Lilly weight loss drug beats Ozempic in head-to-head study - ET HealthWorld | Pharma
The Economic Times· 5 days agoWashington: Patients taking Eli Lilly's new drug Mounjaro achieved significantly greater weight loss...
Gerresheimer core profit meets forecast on weight-loss drug deals pipeline - ETPharma
The Economic Times· 3 days agoGerresheimer: The packaging and medical equipment maker's deals with weight loss drugs makers, such...
Amylyx to rebuild pipeline with $35m Phase III ready GLP-1RA acquisition
Clinical Trials Arena· 3 days agoNo trials have been conducted in either type 2 diabetes (T2D) or obesity where the field of GLP-1RAs...
Gerresheimer core profit meets forecast on weight-loss drug deals pipeline - ET HealthWorld | Pharma
The Economic Times· 3 days agoGerresheimer: The packaging and medical equipment maker's deals with weight loss drugs makers, such...
Pfizer moves forward with once-daily weight loss pill
CNBC Awaaz· 3 days agoThe Pfizer drug is part of the second-generation of weight loss pills, under development by...
Torrent Pharma. Summary: Latest Updates and Details | India Infoline
India Infoline· 5 days agoTorrent Pharmaceuticals Limited, the flagship Company of the Torrent Group, is one of the leading pharmaceutical companies having presence in Indian and global markets. The Company is a dominant ...
Moneycontrol Pro Panorama | Pharma companies step up R&D spends to climb product ladder
CNBC Awaaz· 5 days agoThe Panorama newsletter is sent to Moneycontrol Pro subscribers on market days. It offers easy...